Gilde Healthcare III, a venture capital fund targeting early and growth stage healthcare technology companies in Europe and the USA, has begun fundraising with a target size of €200 million.
Pieter van der Meer
The fund will ideally hold its first close by the end of this year, and limit each investment to 15 percent of the fund’s total committed capital, said Gilde senior partner Pieter van der Meer, in an interview with PEO.
Dutch-based Royal Phillips Electronics, the global conglomerate dealing in healthcare, lighting and lifestyle products, will serve as the fund’s anchor investor. Philips will hold a minority stake in the fund, but a spokesman for the company declined to comment on the exact size of the commitment.
Philips invested in Gilde Healthcare III in order to foster innovation in areas of strategic interest to its healthcare business, the firm said. “Over the past years the venturing community has been instrumental in bringing breakthrough healthcare innovations to the market,” said Steve Rusckowski, chief executive officer of Philips Healthcare, in statement.
Gilde Healthcare Partners, the Dutch venture capital firm responsible for managing the fund, has €300 million under management and is part of Gilde Investment Management. Based in Utrecht in the Netherlands, Gilde also runs a Western European buyout programme and a mid-market BeNeLux programme.
The firm closed Gilde Healthcare II in 2008 with €150 million in committed capital, as reported on PEO.